세계의 주사펜 시장 : 유형, 용도, 최종 사용자, 적응증별 예측(2025-2030년)

The Injection Pen Market was valued at USD 36.67 billion in 2023, expected to reach USD 39.19 billion in 2024, and is projected to grow at a CAGR of 7.79%, to USD 62.02 billion by 2030.

The scope of the injection pen market encompasses its definition as a medical device used for the self-administration of medication, such as insulin, growth hormones, and biologics, offering user-friendly alternatives to traditional syringes. This device is gaining traction due to its necessity in addressing chronic diseases like diabetes, facilitating treatment adherence through improved accuracy and convenience. The application of injection pens spans multiple therapeutic areas, primarily focusing on endocrinology, oncology, and autoimmune diseases, while the end-use scope includes hospitals, clinics, and home care settings, enhancing patient independence and compliance.

Market insights indicate that the injection pen market is experiencing growth driven by factors such as the rising prevalence of chronic diseases, increasing demand for minimally invasive drug delivery devices, and technological advances in smart pen technology, improving dosage precision and patient monitoring. Opportunities arise from the surge in demand for biosimilars and the expansion of partnerships between pharmaceutical companies and device manufacturers. To capitalize on these opportunities, companies could focus on developing pens with enhanced connectivity features and user-friendly designs, catering to an aging population's needs and regulatory approvals in emerging markets.

Challenges include the high cost of advanced injection pens, limited awareness in developing regions, and potential issues related to device malfunctions, which could hinder market growth. Companies face the task of overcoming regulatory hurdles and ensuring sustainability in device production to maintain competitiveness. Innovation opportunities lie in enhancing the pen's digital interface for better integration with healthcare systems, developing eco-friendly materials for sustainable manufacturing, and incorporating AI for personalized drug delivery. The market's nature is highly competitive and evolving, with an emphasis on patient-centric solutions and regulatory compliance to secure market leadership. Fostering collaborations with tech firms for smart pen innovations and enhancing market penetration through robust distribution networks could serve as strategic routes for business growth.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Injection Pen Market

The Injection Pen Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising prevalence of chronic diseases and growing number of regulatory approvals
  • Favorable reimbursement in developed economies and government support
  • Growing application pens by people with diabetes to administer insulin
• Market Restraints
  • High cost associated with injection pens
• Market Opportunities
  • Development of delivery device technology owing to rising injection pen demand
  • Growing investments toward research and development
• Market Challenges
  • Preference towards other modes of treatment

Porter's Five Forces: A Strategic Tool for Navigating the Injection Pen Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Injection Pen Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Injection Pen Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Injection Pen Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Injection Pen Market

A detailed market share analysis in the Injection Pen Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Injection Pen Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Injection Pen Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Injection Pen Market

A strategic analysis of the Injection Pen Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Injection Pen Market, highlighting leading vendors and their innovative profiles. These include Amgen Inc., Antares Pharma, Inc., AstraZeneca plc, Bayer AG, Biocorp Production by Novo Nordisk, Eli Lilly and Company, F. Hoffmann-La Roche AG, Gerresheimer AG, Inolife Sciences Inc., Insulet Corporation, Medtronic plc, Mylan N.V., Nemera Development S.A., Novartis AG, Novo Nordisk A/S, Owen Mumford Ltd., Pfizer Inc., Sanofi S.A., SHL Medical AG, Taiyo Pharma Co., Ltd., Terumo Corporation, Teva Pharmaceuticals Industries Ltd., West Pharmaceutical Services, Inc., Wockhardt Limited, and Ypsomed AG.

Market Segmentation & Coverage

This research report categorizes the Injection Pen Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Type, market is studied across Disposable and Reusable Pens.
• Based on Application, market is studied across Fertility, Growth Hormone Therapy, Insulin Delivery, and Osteoporosis.
• Based on End User, market is studied across Homecare and Hospitals & Clinics.
• Based on Indication, market is studied across Anaphylaxis, Cancer, Cardiovascular Diseases, Diabetes, Multiple Sclerosis, and Rheumatoid Arthritis.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising prevalence of chronic diseases and growing number of regulatory approvals
    • 5.1.1.2. Favorable reimbursement in developed economies and government support
    • 5.1.1.3. Growing application pens by people with diabetes to administer insulin
  • 5.1.2. Restraints
    • 5.1.2.1. High cost associated with injection pens
  • 5.1.3. Opportunities
    • 5.1.3.1. Development of delivery device technology owing to rising injection pen demand
    • 5.1.3.2. Growing investments toward research and development
  • 5.1.4. Challenges
    • 5.1.4.1. Preference towards other modes of treatment
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Injection Pen Market, by Type

• 6.1. Introduction
• 6.2. Disposable
• 6.3. Reusable Pens

7. Injection Pen Market, by Application

• 7.1. Introduction
• 7.2. Fertility
• 7.3. Growth Hormone Therapy
• 7.4. Insulin Delivery
• 7.5. Osteoporosis

8. Injection Pen Market, by End User

• 8.1. Introduction
• 8.2. Homecare
• 8.3. Hospitals & Clinics

9. Injection Pen Market, by Indication

• 9.1. Introduction
• 9.2. Anaphylaxis
• 9.3. Cancer
• 9.4. Cardiovascular Diseases
• 9.5. Diabetes
• 9.6. Multiple Sclerosis
• 9.7. Rheumatoid Arthritis

10. Americas Injection Pen Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Injection Pen Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Injection Pen Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
  • 13.3.1. Aptar Digital Health and SHL Medical partnership to enhance self-injectable therapies through enhanced connectivity and patient experience
  • 13.3.2. Eisai and nippon medac launch Metoject Subcutaneous Injection Pen in Japan to enhance convenience and safety for rheumatoid arthritis patients
  • 13.3.3. Sanofi India launched Soliqua, a daily diabetes injection pen targeting obese adults to improve glycaemic control and reduce hypoglycemia risk
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Amgen Inc.
• 2. Antares Pharma, Inc.
• 3. AstraZeneca plc
• 4. Bayer AG
• 5. Biocorp Production by Novo Nordisk
• 6. Eli Lilly and Company
• 7. F. Hoffmann-La Roche AG
• 8. Gerresheimer AG
• 9. Inolife Sciences Inc.
• 10. Insulet Corporation
• 11. Medtronic plc
• 12. Mylan N.V.
• 13. Nemera Development S.A.
• 14. Novartis AG
• 15. Novo Nordisk A/S
• 16. Owen Mumford Ltd.
• 17. Pfizer Inc.
• 18. Sanofi S.A.
• 19. SHL Medical AG
• 20. Taiyo Pharma Co., Ltd.
• 21. Terumo Corporation
• 22. Teva Pharmaceuticals Industries Ltd.
• 23. West Pharmaceutical Services, Inc.
• 24. Wockhardt Limited
• 25. Ypsomed AG